期刊文献+

新型免疫抑制剂FTY720诱导K562细胞凋亡及其机制 被引量:3

Apoptosis of K562 cells induced by a new immunosuppressive agent FTY720 and its mechanism
下载PDF
导出
摘要 目的:探讨新型免疫抑制剂FTY720诱导K562细胞凋亡的效应及其机制,为临床白血病的治疗提供实验依据。方法:体外培养人白血病K562细胞,分为空白对照组和FTY720处理组,FTY720处理组细胞分别采用6μmol·L-1 FTY720诱导3、6和12h,或采用2、4、6和8μmol·L-1 FTY720处理24h。采用流式细胞术分析细胞凋亡百分率、活性氧(ROS)水平、线粒体膜电位(MMP)和细胞周期。采用WST-1还原法检测FTY720作用下K562细胞增殖抑制率。结果:流式细胞术检测,与空白对照组比较,6μmol·L-1 FTY720诱导细胞3、6和12h后,细胞凋亡率随时间延长而升高(P<0.01);与空白对照组比较,2、4、6和8μmol·L-1FTY720诱导细胞24h后,细胞凋亡率随药物浓度增加而升高(P<0.01)。与空白对照组比较,随FTY720浓度增加,K562细胞内ROS水平增加(P<0.01),同时其MMP下降(P<0.01)。细胞周期分析,与空白对照组比较,随FTY720浓度增加,G0/G1期细胞百分率增加(P<0.05),而S期和G2/M期细胞百分率减少(P<0.05)。WST-1还原法分析,与空白对照组比较,FTY720处理72h后,2、4、6和8μmol·L-1 FTY720处理组K562细胞增殖抑制率[(24.0±4.1)%、(46.4±3.9)%、(67.0±4.8)%和(88.2±5.6)%]明显升高(P<0.01),FTY720对K562细胞的半数抑制浓度(IC50)为5.5μmol·L-1。结论:FTY720可通过导致细胞周期阻滞和激发ROS而诱导细胞凋亡来发挥抗肿瘤作用。 Objective To study the apoptosis of K562 cells induced by a new immunosuppressive agent FTY720 and its mechanism,and to provide experimental basis for the treatment of leukemia in clinic.Methods The K562 cells were cultured in vitro and divided into blank control group and FTY720 treatment group.The K562 cells in FTY720 treatment group were treated with 6μmol·L-1 FTY720 for 3,6,and 12 h,or treated with different concentrations of FTY720 (2,4,6,8μmol·L-1)for 24 h.The apoptosis,level of reactive oxygen species (ROS),mitochondrial membrane potential(MMP)and cell cycle were measured by flow cytometry.The inhibitory rate of proliferation of K562 cells after treated with FTY720 was detected by WST-1 reducting assay.Results The results of flow cytometry showed that the percentages of apoptotic cells were increased after treated with 6μmol·L-1 FTY720 for 3,6,and 12 h with the prolongation of time compared with blank control group(P〈0.01).The percentages of apoptotic cells were also increased after treated with different concentrations of FTY720 for 24 h compared with blank control group(P〈0.01).Compared with blank control group,the ROS levels were increased with the increasing of FTY720 concentration,while the MMP was decreased(P〈0.01).Compared with blank control group,the percentage of cells at G0/G1 phase was increased,while those at S and G2/M phases were decreased with the increasing of FTY720 concentration (P〈0.05).The WST-1 reduction assay results indicated that the inhibitory rates of proliferation of K562 cells after treated with 2,4,6,and 8μmol·L-1 FTY720 for 72 h were (24.0±4.1)%,(46.4±3.9)%,(67.0±4.8)%,and (88.2±5.6)%,respectively,compared with blank control group.The concentration of FTY720 to result the inhibitory rate of 50% (IC50 )on K562 cells was 5.5μmol·L-1 .Conclusion FTY720 could inhibit the proliferation of K562 cells by blocking cell cycle and inducing apoptosis through provoking ROS.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2014年第6期1161-1165,共5页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题(82102953) 吉林省科技厅中青年科技创新领军人才及团队资助课题(20130521018JH) 吉林省科技厅重点科技攻关资助课题(20140203012YY) 吉林省教育厅科研基金资助课题(2012第487号 2012第420号)
关键词 FTY720 细胞凋亡 活性氧 细胞周期 FTY720 apoptosis reactive oxygen species cell cycle
  • 相关文献

参考文献14

二级参考文献76

  • 1[1]Haruhito A, Shiro T, Naotsugu I, et al. Marked prevention of tumor growth and metastasis by a novel immunosuppressive Agent, FTY720, in Mouse Breast [J]. Cancer Research,2002, 62(5): 1 410- 1 419.
  • 2[2]Masayuki F, Xiao KL, Yusuke K, et al. Distinct pathways of apoptosis triggered by FTY720, etoposide, and anti-Fas antibody in human T-Lymphoma cell line (Jurkat Cells) [J].J Pharmacol Exp Ther, 2002, 300(3): 939-945.
  • 3[5]Klemens B, Robert L, Schmouder A, et al. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients [J]. J Am Soc Nephrol, 2002, 13 (4):1 073- 1 083.
  • 4[6]Kovarik JM, Schmouder R, Barilla D, et al. Multiple-dose FTY720: tolerability, pharmacokinetics, and lymphocyte responses in healthy subjects [J]. J Clin Pharmacol, 2004,44(5): 532- 537.
  • 5[7]Brinkmann V , Davis MD , Heise CE , et al . The immune modulator FTY720 targets sphingosine 1-phosphate receptors[J]. J Biol Chem, 2002, 277(24): 21 453 - 21 457.
  • 6[8]Tanaka T, Takahara S, Hatori M, et al . A novel immuno suppressive drug, FTY720, prevents the cancer progression induced by cyclosporine [J]. Cancer Lett, 2002,181 (2):165- 171.
  • 7[9]Graler MH , Goetzl EJ . The immunosuppressant FTY720down-regulates sphingosine 1-phosphate G protein-coupled receptors [J]. FASEB J, 2004, 18(3): 551-553.
  • 8[10]Matloubian M , Lo CG , Cinamon G , et al . Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 [J]. Nature, 2004,427(6 972):355 - 360.
  • 9[11]Andreas B, Frederic B, Piroska D, et al. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases [J]. J Biol Chem, 2003, 278(48): 47 408 - 47 415.
  • 10[12]Richard K. The therapeutic potential of modulating the ceramide/sphingomyelin pathway [J]. J Clin Invest, 2002,110(1): 3-8.

共引文献30

同被引文献24

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部